Bush Reelection Is "Very Good" For Drug Manufacturers, GSK Says
This article was originally published in The Pink Sheet Daily
Executive Summary
President Bush's reelection is good for the pharmaceutical industry because of his position on prescription drug importation, GlaxoSmithKline VP-Federal Government Relations Sally Walsh said Nov. 17
You may also be interested in...
House May Be Stopping Point For Rx Importation Bills – Hill Staffer
Aide to House Ways & Means Health Subcommittee Chairman Johnson argues that House leaders will be better able to avoid consideration of importation legislation than the Senate. Democratic opponent of the concept suggests drug imports may violate WTO rules.
House May Be Stopping Point For Rx Importation Bills – Hill Staffer
Aide to House Ways & Means Health Subcommittee Chairman Johnson argues that House leaders will be better able to avoid consideration of importation legislation than the Senate. Democratic opponent of the concept suggests drug imports may violate WTO rules.
GOP Victory Won’t End Rx Import Debate: Seven New Senators Support Open Borders
Five Republicans and two Democrats newly elected to the Senate have stated their support for prescription drug importation. The expanded Republican majorities in the House and Senate could offer pharmaceutical manufacturers an opportunity to negotiate an acceptable import program in the face of continuing public pressure.